E Fund Management’s Cabaletta Bio CABA Stock Holding History

E Fund Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-280,133	Closed	-$1.32M	–	401
2024 Q3	$1.32M	Sell	280,133 -6,291	-2%	-$36.4K	0.07%	119
2024 Q2	$2.14M	Buy	286,424 +269,675	+1,610%	+$3.31M	0.12%	81
2024 Q1	$286K	Buy	16,749 +5,510	+49%	+$118K	0.02%	282
2023 Q4	$255K	Buy	+11,239	New	+$189K	0.02%	253

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

E Fund Management's CABA Position: Q4 2024 in Review

E Fund Management sold out of Cabaletta Bio (CABA) in Q4 2024, closing a stake of 280,133 shares — an estimated $1.32M sold.

E Fund Management first reported a position in CABA in Q4 2023 and held it in 4 quarters. The position peaked at $2.14M in Q2 2024. 108 funds tracked by Wall St. Rank hold CABA as of Q4 2024.

E Fund Management reported no remaining Cabaletta Bio position as of Q4 2024 after selling out during the quarter.
E Fund Management sold 280,133 Cabaletta Bio shares in Q4 2024, an estimated $1.32M.
E Fund Management first reported a position in Cabaletta Bio in Q4 2023 and held it in 4 quarters.
E Fund Management's Cabaletta Bio position peaked at $2.14M in Q2 2024.
108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2024.

Based on E Fund Management's 13F filing for Q4 2024, filed 7 Feb 2025.